Successful intravenous thrombolysis in a patient with ischemic stroke, after reversal of Dabigatran with Idarucizumab – A case report

---

Case Report

Author Details : Nasli R Ichaporia, Sanjay Pawar, Gajanan Patil, Amod Tilak, Arun Kumar Dahiya*

Volume : 6, Issue : 4, Year : 2020

Article Page : 327-329

https://doi.org/10.18231/j.ijn.2020.059

Suggest article by email

Get Permission

---

Abstract

There remains a risk of ischemic strokes in patients of atrial fibrillation receiving oral anticoagulants. Systemic thrombolysis in such cases poses a challenge, but may be possible after reversal of anticoagulant effect. We report a case of 61-year old male patient with non-valvular atrial fibrillation who was taking dabigatran. The patient developed ischemic stroke few hours after taking the last dose of the anticoagulant. Reversal of dabigatran was achieved using idarucizumab, and the patient was successfully thrombolysed. This case-report adds to the growing evidence that such a strategy is now possible with the advent of reversal agents against non-vitamin K antagonist oral anticoagulants.

Keywords: Stroke, Dabigatran, Idarucizumab, Reversal.

How to cite : Ichaporia N R, Pawar S, Patil G, Tilak A, Dahiya A K, Successful intravenous thrombolysis in a patient with ischemic stroke, after reversal of Dabigatran with Idarucizumab – A case report. IP Indian J Neurosci 2020;6(4):327-329

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.